TreeWAS – Variant ID: rs843532

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C44 Other malignant neoplasms of skin	0.798	0.202	0.000
C44.7 Skin of lower limb, including hip	0.796	0.204	0.000
C44.4 Skin of scalp and neck	0.792	0.208	0.000
C44.2 Skin of ear and external auricular canal	0.759	0.241	0.000
C44.5 Skin of trunk	0.758	0.242	0.000
C44.3 Skin of other and unspecified parts of face	0.628	0.372	0.000
C44.8 Overlapping lesion of skin	0.572	0.428	0.000
C44.6 Skin of upper limb, including shoulder	0.546	0.454	0.000
C44.0 Skin of lip	0.530	0.470	0.000
C44.9 Malignant neoplasm of skin, unspecified	0.445	0.555	0.000
C44.1 Skin of eyelid, including canthus	0.413	0.587	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.158	0.842	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.108	0.892	0.000
N13 Obstructive and reflux uropathy	0.080	0.920	0.000
N13.4 Hydroureter	0.072	0.928	0.000
N13.3 Other and unspecified hydronephrosis	0.068	0.932	0.000
N13.7 Vesicoureteral-reflux-associated uropathy	0.066	0.934	0.000
N13.9 Obstructive and reflux uropathy, unspecified	0.060	0.939	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.058	0.942	0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.056	0.944	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.054	0.946	0.000
S02.4 Fracture of malar and maxillary bones	0.052	0.948	0.000
S02 Fracture of skull and facial bones	0.051	0.949	0.000
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.048	0.952	0.000
S02.8 Fractures of other skull and facial bones	0.048	0.952	0.000
S02.1 Fracture of base of skull	0.047	0.953	0.000
N13.6 Pyonephrosis	0.047	0.953	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.045	0.954	0.000
S02.0 Fracture of vault of skull	0.045	0.955	0.000
S02.10 Fracture of base of skull (closed)	0.045	0.955	0.000
S02.5 Fracture of tooth	0.043	0.956	0.000
S02.9 Fracture of skull and facial bones, part unspecified	0.043	0.956	0.000
S02.00 Fracture of vault of skull (closed)	0.041	0.959	0.000
N10-N16 Renal tubulo-interstitial diseases	0.039	0.961	0.000
S02.50 Fracture of tooth (closed)	0.038	0.962	0.000
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.038	0.962	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.037	0.962	0.000
S02.81 Fractures of other skull and facial bones (open)	0.034	0.966	0.000
S02.11 Fracture of base of skull (open)	0.034	0.966	0.000
S02.2 Fracture of nasal bones	0.034	0.966	0.000
S02.6 Fracture of mandible	0.033	0.967	0.000
S02.7 Multiple fractures involving skull and facial bones	0.033	0.967	0.000
S02.01 Fracture of vault of skull (open)	0.033	0.967	0.000
N10 Acute tubulo-interstitial nephritis	0.032	0.968	0.000
S02.51 Fracture of tooth (open)	0.031	0.969	0.000
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.031	0.969	0.000
N15 Other renal tubulo-interstitial diseases	0.030	0.969	0.000
N13.8 Other obstructive and reflux uropathy	0.030	0.970	0.000
S02.3 Fracture of orbital floor	0.029	0.971	0.000
N11 Chronic tubulo-interstitial nephritis	0.029	0.971	0.000
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.028	0.972	0.000
C43 Malignant melanoma of skin	0.028	0.972	0.000
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.026	0.974	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.025	0.975	0.000
S02.21 Fracture of nasal bones (open)	0.025	0.975	0.000
N15.1 Renal and perinephric abscess	0.024	0.976	0.000
S02.61 Fracture of mandible (open)	0.024	0.976	0.000
S02.71 Multiple fractures involving skull and facial bones (open)	0.024	0.976	0.000
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.024	0.976	0.000
N11.1 Chronic obstructive pyelonephritis	0.022	0.977	0.000
N15.9 Renal tubulo-interstitial disease, unspecified	0.022	0.978	0.000
N15.8 Other specified renal tubulo-interstitial diseases	0.022	0.978	0.000
N15.0 Balkan nephropathy	0.022	0.978	0.000
C43.4 Malignant melanoma of scalp and neck	0.022	0.978	0.000
S02.20 Fracture of nasal bones (closed)	0.022	0.978	0.000
S02.31 Fracture of orbital floor (open)	0.021	0.979	0.000
N11.8 Other chronic tubulo-interstitial nephritis	0.021	0.979	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.021	0.979	0.000
S02.60 Fracture of mandible (closed)	0.021	0.979	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.021	0.979	0.000
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.020	0.979	0.000
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.020	0.979	0.000
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.020	0.979	0.000
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.020	0.979	0.000
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.020	0.979	0.000
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.020	0.979	0.000
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.020	0.979	0.000
C43.8 Overlapping malignant melanoma of skin	0.020	0.980	0.000
C43.0 Malignant melanoma of lip	0.020	0.980	0.000
S02.70 Multiple fractures involving skull and facial bones (closed)	0.020	0.980	0.000
N14.4 Toxic nephropathy, not elsewhere classified	0.019	0.981	0.000
N14.3 Nephropathy induced by heavy metals	0.019	0.981	0.000
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance	0.019	0.981	0.000
N14.0 Analgesic nephropathy	0.019	0.981	0.000
I60.9 Subarachnoid haemorrhage, unspecified	0.019	0.981	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.018	0.982	0.000
N14.1 Nephropathy induced by other drugs, medicaments and biological substances	0.017	0.983	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.016	0.984	0.000
C43.9 Malignant melanoma of skin, unspecified	0.015	0.985	0.000
C43.5 Malignant melanoma of trunk	0.015	0.985	0.000
I60 Subarachnoid haemorrhage	0.014	0.985	0.000
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.014	0.986	0.000
H00.1 Chalazion	0.014	0.986	0.000
S02.30 Fracture of orbital floor (closed)	0.014	0.986	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.012	0.988	0.000
I60.8 Other subarachnoid haemorrhage	0.012	0.988	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.012	0.988	0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.012	0.988	0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.011	0.989	0.000
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.011	0.989	0.000
C83.3 Large cell (diffuse)	0.011	0.989	0.000
I60.5 Subarachnoid haemorrhage from vertebral artery	0.011	0.989	0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.011	0.989	0.000
I60.4 Subarachnoid haemorrhage from basilar artery	0.010	0.990	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.010	0.990	0.000
C83.0 Small cell (diffuse)	0.009	0.991	0.000
C83.1 Small cleaved cell (diffuse)	0.008	0.992	0.000
K07.6 Temporomandibular joint disorders	0.000	0.992	0.008
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.992	0.008
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.008	0.992	0.000
C83.7 Burkitt's tumour	0.007	0.992	0.000
U80.1 Methicillin resistant agent	0.000	0.993	0.007
H00 Hordeolum and chalazion	0.007	0.993	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.007	0.993	0.000
C83.6 Undifferentiated (diffuse)	0.007	0.993	0.000
C83.5 Lymphoblastic (diffuse)	0.007	0.993	0.000
C83.4 Immunoblastic (diffuse)	0.007	0.993	0.000
C83.2 Mixed small and large cell (diffuse)	0.007	0.993	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.007	0.993	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.007	0.993	0.000
T43.2 Other and unspecified antidepressants	0.000	0.994	0.006
K07 Dentofacial anomalies [including malocclusion]	0.000	0.994	0.006
H00.0 Hordeolum and other deep inflammation of eyelid	0.006	0.994	0.000
G81.9 Hemiplegia, unspecified	0.000	0.995	0.005
K07.1 Anomalies of jaw-cranial base relationship	0.000	0.995	0.005
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.005	0.995	0.000
K07.3 Anomalies of tooth position	0.000	0.995	0.005
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.005	0.995	0.000
M06.9 Rheumatoid arthritis, unspecified	0.005	0.995	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.005	0.995	0.000
I71.3 Abdominal aortic aneurysm, ruptured	0.005	0.995	0.000
N97.9 Female infertility, unspecified	0.005	0.995	0.000
N97.1 Female infertility of tubal origin	0.005	0.995	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.005	0.995	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.004	0.995	0.000
K07.4 Malocclusion, unspecified	0.000	0.995	0.004
U80 Agent resistant to penicillin and related antibiotics	0.000	0.996	0.004
N97 Female infertility	0.004	0.996	0.000
K07.8 Other dentofacial anomalies	0.000	0.996	0.004
K07.5 Dentofacial functional abnormalities	0.000	0.996	0.004
K07.0 Major anomalies of jaw size	0.000	0.996	0.004
N97.8 Female infertility of other origin	0.004	0.996	0.000
C95 Leukaemia of unspecified cell type	0.004	0.996	0.000
K07.2 Anomalies of dental arch relationship	0.000	0.996	0.004
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.004	0.996	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
I08.2 Disorders of both aortic and tricuspid valves	0.004	0.996	0.000
I08 Multiple valve diseases	0.004	0.996	0.000
C95.9 Leukaemia, unspecified	0.004	0.996	0.000
I69 Sequelae of cerebrovascular disease	0.000	0.996	0.004
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.004	0.996	0.000
I71 Aortic aneurysm and dissection	0.004	0.996	0.000
C95.0 Acute leukaemia of unspecified cell type	0.004	0.996	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.004	0.996	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.996	0.004
K07.9 Dentofacial anomaly, unspecified	0.000	0.996	0.003
C81 Hodgkin's disease	0.004	0.996	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.003	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.996	0.004
K50.9 Crohn's disease, unspecified	0.000	0.997	0.003
N97.4 Female infertility associated with male factors	0.003	0.997	0.000
N97.3 Female infertility of cervical origin	0.003	0.997	0.000
N97.2 Female infertility of uterine origin	0.003	0.997	0.000
N97.0 Female infertility associated with anovulation	0.003	0.997	0.000
U80.0 Penicillin resistant agent	0.000	0.997	0.003
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.003	0.997	0.000
N23 Unspecified renal colic	0.003	0.997	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.003	0.997	0.000
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.003	0.997	0.000
C93 Monocytic leukaemia	0.003	0.997	0.000
I71.1 Thoracic aortic aneurysm, ruptured	0.003	0.997	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.997	0.003
C81.7 Other Hodgkin's disease	0.003	0.997	0.000
C95.7 Other leukaemia of unspecified cell type	0.003	0.997	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.003	0.997	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.003	0.997	0.000
C88 Malignant immunoproliferative diseases	0.003	0.997	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.003	0.997	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
C94 Other leukaemias of specified cell type	0.003	0.997	0.000
C86 Other specified types of T/NK-cell lymphoma	0.003	0.997	0.000
C81.0 Lymphocytic predominance	0.003	0.997	0.000
E55.9 Vitamin D deficiency, unspecified	0.000	0.997	0.003
N89.8 Other specified noninflammatory disorders of vagina	0.000	0.997	0.003
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.997	0.003
N70.1 Chronic salpingitis and oophoritis	0.003	0.997	0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
I08.9 Multiple valve disease, unspecified	0.003	0.997	0.000
C81.1 Nodular sclerosis	0.003	0.997	0.000
I08.0 Disorders of both mitral and aortic valves	0.003	0.997	0.000
C84.4 Peripheral T-cell lymphoma	0.003	0.997	0.000
I71.8 Aortic aneurysm of unspecified site, ruptured	0.003	0.997	0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.003	0.997	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.003	0.997	0.000
G45.4 Transient global amnesia	0.003	0.997	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.997	0.003
C90 Multiple myeloma and malignant plasma cell neoplasms	0.003	0.997	0.000
M06 Other rheumatoid arthritis	0.003	0.997	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.003	0.997	0.000
C81.3 Lymphocytic depletion	0.003	0.997	0.000
C81.2 Mixed cellularity	0.003	0.997	0.000
I69.3 Sequelae of cerebral infarction	0.000	0.997	0.003
S32.10 Fracture of sacrum (closed)	0.000	0.997	0.003
I71.0 Dissection of aorta [any part]	0.003	0.997	0.000
T84.1 Mechanical complication of internal fixation device of bones of limb	0.003	0.997	0.000
C91 Lymphoid leukaemia	0.003	0.997	0.000
K14.0 Glossitis	0.000	0.997	0.003
C93.1 Chronic monocytic leukaemia	0.003	0.997	0.000
C91.4 Hairy-cell leukaemia	0.003	0.997	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.003	0.997	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.003	0.997	0.000
C93.9 Monocytic leukaemia, unspecified	0.002	0.997	0.000
C93.7 Other monocytic leukaemia	0.002	0.997	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.002	0.997	0.000
C93.2 Subacute monocytic leukaemia	0.002	0.997	0.000
C93.0 Acute monocytic leukaemia	0.002	0.997	0.000
E16.2 Hypoglycaemia, unspecified	0.000	0.997	0.003
M06.0 Seronegative rheumatoid arthritis	0.003	0.997	0.000
N04.9 Unspecified	0.003	0.997	0.000
M81.98 Osteoporosis, unspecified (Other)	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.003	0.997	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.002	0.997	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.002	0.997	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.002	0.997	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.002	0.997	0.000
C84.3 Lymphoepithelioid lymphoma	0.002	0.997	0.000
C84.2 T-zone lymphoma	0.002	0.997	0.000
C84.1 Sezary's diease	0.002	0.997	0.000
C84.0 Mycosis fungoides	0.002	0.997	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.002	0.997	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.002	0.997	0.000
C86.4 Blastic NK-cell lymphoma	0.002	0.997	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.002	0.997	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.002	0.997	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.002	0.997	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.002	0.997	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.002	0.997	0.000
C88.7 Other malignant immunoproliferative diseases	0.002	0.997	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.002	0.997	0.000
C88.3 Immunoproliferative small intestinal disease	0.002	0.997	0.000
C88.2 Gamma heavy chain disease	0.002	0.997	0.000
C88.1 Alpha heavy chain disease	0.002	0.997	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.002	0.997	0.000
C94.7 Other specified leukaemias	0.002	0.997	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.002	0.997	0.000
C94.5 Acute myelofibrosis	0.002	0.997	0.000
C94.4 Acute panmyelosis	0.002	0.997	0.000
C94.3 Mast cell leukaemia	0.002	0.997	0.000
C94.2 Acute megakaryoblastic leukaemia	0.002	0.997	0.000
C94.1 Chronic erythraemia	0.002	0.997	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.002	0.997	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.997	0.000
C96.8 Histiocytic sarcoma	0.002	0.997	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.997	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.002	0.997	0.000
C96.3 True histiocytic lymphoma	0.002	0.997	0.000
C96.2 Malignant mast cell tumour	0.002	0.997	0.000
C96.1 Malignant histiocytosis	0.002	0.997	0.000
C96.0 Letterer-Siwe disease	0.002	0.997	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.003	0.997	0.000
C82.3 Follicular lymphoma grade IIIa	0.002	0.997	0.000
C92 Myeloid leukaemia	0.002	0.997	0.000
C82.6 Cutaneous follicle centre lymphoma	0.002	0.997	0.000
C82.5 Diffuse follicle centre lymphoma	0.002	0.997	0.000
C82.4 Follicular lymphoma grade IIIb	0.002	0.997	0.000
C82.2 Large cell, follicular	0.002	0.997	0.000
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.002	0.997	0.000
C90.3 Solitary plasmacytoma	0.002	0.998	0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.002	0.998	0.000
C90.1 Plasma cell leukaemia	0.002	0.998	0.000
C81.9 Hodgkin's disease, unspecified	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.002	0.998	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.998	0.002
M06.8 Other specified rheumatoid arthritis	0.002	0.998	0.000
M06.2 Rheumatoid bursitis	0.002	0.998	0.000
M06.1 Adult-onset Still's disease	0.002	0.998	0.000
N48.6 Balanitis xerotica obliterans	0.002	0.998	0.000
M06.3 Rheumatoid nodule	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
Q28.2 Arteriovenous malformation of cerebral vessels	0.002	0.998	0.000
N04 Nephrotic syndrome	0.002	0.998	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.002	0.998	0.000
C91.7 Other lymphoid leukaemia	0.002	0.998	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.002	0.998	0.000
C91.5 Adult T-cell leukaemia	0.002	0.998	0.000
C91.3 Prolymphocytic leukaemia	0.002	0.998	0.000
C91.2 Subacute lymphocytic leukaemia	0.002	0.998	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.000	0.998	0.002
I08.8 Other multiple valve diseases	0.002	0.998	0.000
N03 Chronic nephritic syndrome	0.002	0.998	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
G81 Hemiplegia	0.000	0.998	0.002
C90.2 Plasmacytoma, extramedullary	0.002	0.998	0.000
C91.9 Lymphoid leukaemia, unspecified	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.002	0.998	0.000
N03.9 Unspecified	0.002	0.998	0.000
N03.8 Other	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.998	0.000
M06.08 Seronegative rheumatoid arthritis (Other)	0.002	0.998	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.002	0.998	0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.002	0.998	0.000
M06.04 Seronegative rheumatoid arthritis (Hand)	0.002	0.998	0.000
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.002	0.998	0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.002	0.998	0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.002	0.998	0.000
U51 Admission status on psychiatric patients	0.000	0.998	0.002
G99.2 Myelopathy in diseases classified elsewhere	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
X41.9 Unspecified place	0.000	0.998	0.002
C91.0 Acute lymphoblastic leukaemia	0.002	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.998	0.000
C92.7 Other myeloid leukaemia	0.002	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.002	0.998	0.000
C92.3 Myeloid sarcoma	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.998	0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.002	0.998	0.000
H05.0 Acute inflammation of orbit	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
N05 Unspecified nephritic syndrome	0.002	0.998	0.000
N00-N08 Glomerular diseases	0.002	0.998	0.000
M06.32 Rheumatoid nodule (Upper arm)	0.002	0.998	0.000
M06.30 Rheumatoid nodule (Multiple sites)	0.002	0.998	0.000
S32.1 Fracture of sacrum	0.000	0.998	0.002
M21.06 Valgus deformity, not elsewhere classified (Lower leg)	0.002	0.998	0.000
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.998	0.002
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.998	0.002
N60.3 Fibrosclerosis of breast	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
M06.37 Rheumatoid nodule (Ankle and foot)	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.002	0.998	0.000
N05.8 Other	0.002	0.998	0.000
H04.5 Stenosis and insufficiency of lachrymal passages	0.002	0.998	0.000
Y84.6 Urinary catheterisation	0.002	0.998	0.000
U50 Level of care administered to neonates	0.000	0.998	0.002
U07 Emergency use of U07	0.000	0.998	0.002
U06 Emergency use of U06	0.000	0.998	0.002
U04 Severe acute respiratory syndrome [SARS]	0.000	0.998	0.002
U52 First in a series of a regular day/night admissions	0.000	0.998	0.002
M06.19 Adult-onset Still's disease (Site unspecified)	0.002	0.998	0.000
M06.18 Adult-onset Still's disease (Other)	0.002	0.998	0.000
M06.17 Adult-onset Still's disease (Ankle and foot)	0.002	0.998	0.000
M06.16 Adult-onset Still's disease (Lower leg)	0.002	0.998	0.000
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.002	0.998	0.000
M06.14 Adult-onset Still's disease (Hand)	0.002	0.998	0.000
M06.13 Adult-onset Still's disease (Forearm)	0.002	0.998	0.000
M06.12 Adult-onset Still's disease (Upper arm)	0.002	0.998	0.000
M06.11 Adult-onset Still's disease (Shoulder region)	0.002	0.998	0.000
M06.10 Adult-onset Still's disease (Multiple sites)	0.002	0.998	0.000
M06.29 Rheumatoid bursitis (Site unspecified)	0.002	0.998	0.000
M06.28 Rheumatoid bursitis (Other)	0.002	0.998	0.000
M06.27 Rheumatoid bursitis (Ankle and foot)	0.002	0.998	0.000
M06.26 Rheumatoid bursitis (Lower leg)	0.002	0.998	0.000
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.002	0.998	0.000
M06.24 Rheumatoid bursitis (Hand)	0.002	0.998	0.000
M06.23 Rheumatoid bursitis (Forearm)	0.002	0.998	0.000
M06.22 Rheumatoid bursitis (Upper arm)	0.002	0.998	0.000
M06.21 Rheumatoid bursitis (Shoulder region)	0.002	0.998	0.000
M06.20 Rheumatoid bursitis (Multiple sites)	0.002	0.998	0.000
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.002	0.998	0.000
M06.88 Other specified rheumatoid arthritis (Other)	0.002	0.998	0.000
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.002	0.998	0.000
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.002	0.998	0.000
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.002	0.998	0.000
M06.84 Other specified rheumatoid arthritis (Hand)	0.002	0.998	0.000
M06.83 Other specified rheumatoid arthritis (Forearm)	0.002	0.998	0.000
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.002	0.998	0.000
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.002	0.998	0.000
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.002	0.998	0.000
N32.3 Diverticulum of bladder	0.000	0.998	0.002
S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)	0.002	0.998	0.000
M06.39 Rheumatoid nodule (Site unspecified)	0.002	0.998	0.000
M06.38 Rheumatoid nodule (Other)	0.002	0.998	0.000
M06.36 Rheumatoid nodule (Lower leg)	0.002	0.998	0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.002	0.998	0.000
M06.33 Rheumatoid nodule (Forearm)	0.002	0.998	0.000
M06.31 Rheumatoid nodule (Shoulder region)	0.002	0.998	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
N04.8 Other	0.002	0.998	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N04.6 Dense deposit disease	0.002	0.998	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N04.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N04.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N04.0 Minor glomerular abnormality	0.002	0.998	0.000
M06.4 Inflammatory polyarthropathy	0.002	0.998	0.000
N03.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N03.6 Dense deposit disease	0.002	0.998	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N03.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N03.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N03.0 Minor glomerular abnormality	0.002	0.998	0.000
N05.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
H05 Disorders of orbit	0.002	0.998	0.000
G81.0 Flaccid hemiplegia	0.000	0.998	0.002
N08.5 Glomerular disorders in systemic connective tissue disorders	0.002	0.998	0.000
Y84.8 Other medical procedures	0.002	0.998	0.000
K50.1 Crohn's disease of large intestine	0.000	0.998	0.002
N05.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.002	0.998	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.002	0.998	0.000
N70 Salpingitis and oophoritis	0.002	0.998	0.000
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
N90.8 Other specified noninflammatory disorders of vulva and perineum	0.002	0.998	0.000
H05.2 Exophthalmic conditions	0.002	0.998	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.998	0.002
C90.0 Multiple myeloma	0.002	0.998	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.998	0.001
M25.56 Pain in joint (Lower leg)	0.002	0.998	0.000
S32.11 Fracture of sacrum (open)	0.000	0.998	0.002
N05.6 Dense deposit disease	0.002	0.998	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N05.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N05.0 Minor glomerular abnormality	0.002	0.998	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.002	0.998	0.000
N06 Isolated proteinuria with specified morphological lesion	0.002	0.998	0.000
N01 Rapidly progressive nephritic syndrome	0.002	0.998	0.000
N00 Acute nephritic syndrome	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.998	0.002
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.998	0.001
U06.9 Emergency use of U06.9	0.000	0.998	0.001
U06.8 Emergency use of U06.8	0.000	0.998	0.001
U06.7 Emergency use of U06.7	0.000	0.998	0.001
U06.6 Emergency use of U06.6	0.000	0.998	0.001
U06.5 Emergency use of U06.5	0.000	0.998	0.001
U06.4 Emergency use of U06.4	0.000	0.998	0.001
U06.3 Emergency use of U06.3	0.000	0.998	0.001
U06.2 Emergency use of U06.2	0.000	0.998	0.001
U06.1 Emergency use of U06.1	0.000	0.998	0.001
U06.0 Emergency use of U06.0	0.000	0.998	0.001
U07.9 Emergency use of U07.9	0.000	0.998	0.001
U07.8 Emergency use of U07.8	0.000	0.998	0.001
U07.7 Emergency use of U07.7	0.000	0.998	0.001
U07.6 Emergency use of U07.6	0.000	0.998	0.001
U07.5 Emergency use of U07.5	0.000	0.998	0.001
U07.4 Emergency use of U07.4	0.000	0.998	0.001
U07.3 Emergency use of U07.3	0.000	0.998	0.001
U07.2 Emergency use of U07.2	0.000	0.998	0.001
U07.1 Emergency use of U07.1	0.000	0.998	0.001
U07.0 Emergency use of U07.0	0.000	0.998	0.001
U50.9 Inquest Adjourned Death	0.000	0.998	0.001
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.998	0.001
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.998	0.001
U50.1 Level of care administered to neonates (Special Care)	0.000	0.998	0.001
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.998	0.001
T39.0 Salicylates	0.000	0.998	0.002
E55 Vitamin D deficiency	0.000	0.998	0.002
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.002	0.998	0.000
G81.1 Spastic hemiplegia	0.000	0.998	0.001
M06.48 Inflammatory polyarthropathy (Other)	0.001	0.998	0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.001	0.998	0.000
M06.46 Inflammatory polyarthropathy (Lower leg)	0.001	0.998	0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.001	0.998	0.000
M06.44 Inflammatory polyarthropathy (Hand)	0.001	0.998	0.000
M06.43 Inflammatory polyarthropathy (Forearm)	0.001	0.998	0.000
M06.42 Inflammatory polyarthropathy (Upper arm)	0.001	0.998	0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.001	0.998	0.000
M19.98 Arthrosis, unspecified (Other)	0.000	0.998	0.002
H05.9 Disorder of orbit, unspecified	0.001	0.998	0.000
H05.5 Retained (old) foreign body following penetrating wound of orbit	0.001	0.998	0.000
H05.4 Enophthalmos	0.001	0.998	0.000
H05.3 Deformity of orbit	0.001	0.998	0.000
H05.1 Chronic inflammatory disorders of orbit	0.001	0.998	0.000
I67.9 Cerebrovascular disease, unspecified	0.000	0.998	0.002
K50 Crohn's disease [regional enteritis]	0.000	0.998	0.002
J94.2 Haemothorax	0.000	0.998	0.002
N70.0 Acute salpingitis and oophoritis	0.001	0.998	0.000
E16 Other disorders of pancreatic internal secretion	0.000	0.998	0.002
I67.2 Cerebral atherosclerosis	0.000	0.998	0.002
N08.8 Glomerular disorders in other diseases classified elsewhere	0.001	0.998	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.001	0.998	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.001	0.998	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.001	0.998	0.000
N18.8 Other chronic renal failure	0.002	0.998	0.000
M06.34 Rheumatoid nodule (Hand)	0.001	0.998	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.998	0.001
I78.1 Naevus, nonneoplastic	0.002	0.998	0.000
N05.9 Unspecified	0.001	0.998	0.000
N18.2 Chronic kidney disease, stage 2	0.002	0.998	0.000
M11.26 Other chondrocalcinosis (Lower leg)	0.002	0.998	0.000
G95.8 Other specified diseases of spinal cord	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations